ASTRAZENECA UK LIMITED: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyCambridgeEast of EnglandMain market: Pharmaceutical products

Official UK PPONPLQN-2183-WJTPWebsiteastrazeneca.co.uk ↗

Procedures with an award2227 award records
i

How many tenders this supplier has won.

Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.

Public authorities4named on published awards
i

How many different public bodies have awarded to this supplier.

Buyers named on its awards, with duplicate names merged.

Attributable award value£226mnet · on 4 of 27 award records · single-supplier, no ceilings
i

How much this supplier has won, by published values.

Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.

Not turnover. Not every award publishes a value.

Last 12 months2awards · 7 in the prior 24 months · last 1 Jun 2026
i

Awards to this supplier in the last 12 months.

Award records dated in the last 12 months, against the two years before.

Contracts ending ≤18 months1end date on 17 of 27 awards
i

Contracts that finish in the next 18 months.

Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.

An end date does not confirm a new procurement.

Buyer regions2most often Greater London
i

In which regions this supplier wins work.

The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.

Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.

Where they win
i

In which categories this supplier wins.

Distinct awards by the main category of the lot, or of the procedure when no lot is named. Repeat publications count once.

An award counts once in each class it covers; classes can overlap.

Active awards, plus pending awards whose standstill has ended or was not published.

27 awards (24 for a named lot, 89%, 3 for a whole procedure with no lot named) · top CPV classes, shares of all 27 awards. An award may cover more than one class.

3360 Pharmaceutical products24 awards · 89% · 21 awards naming a lot + 3 whole-procedure awards
Attributable award value
i

How much this supplier has won, by published values.

Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.

Not turnover. Not every award publishes a value.

£226mOn 4 of 27 award records; the five largest make 100%. Largest rows below.
Typical attributable award
i

What one of this supplier’s wins is usually worth.

Middle value of the same awards as the total above.

£542k middle valuemoderate · n=4
Largest published awards
i

The biggest published awards.

Awards to a single supplier with a published value, largest first, so you can check the totals against the notice.

A repeated framework total can appear here. Open the notice to check.

AuthorityAwardedTermPublished value
Live Attenuated Influenza Vaccine 2026/2027Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency——£225,408,000 †
For the supply of Pulmicort Turbohaler 400Department of Health & Social Care——£1,083,200 †
Contract for the supply of live attenuated intranasal influenza vaccineDepartment of Health & Social Care—4 yrs£1 †
Live attenuated influenza vaccine (2022)Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency——£1 †

Where their buyers are
i

In which regions this supplier wins work.

The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.

Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.

ITL1 region of the buyer office · known for 22 of 22 awarded procedures · each procedure counts once

Greater London18 procedures · 82%
North West England4 procedures · 18%

Bidding record
i

Competitions this supplier is known to have bid in.

Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.

Procurement Act 2023 award notices name every bidder · 2 notices name this supplier since 20 Aug 2025 · observed bids, not an estimate

Contract lots contested
i

Competitions this supplier is known to have bid in.

Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.

0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i

Frameworks and DPS this supplier got onto.

Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.

2 of 2
Authorities bid for
i

How many public bodies this supplier has bid to.

Buyers on notices that name it as a bidder, win or lose.

1
NoticeAuthorityOutcomeBiddersPublished
NHS National Branded Interim - 1 June 2026framework/DPSNHS Englandappointed5322 May 2026
NHS National Framework for Transition products (Nilotinib and Ticagrelor)framework/DPSNHS Englandappointed1720 Aug 2025

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Which public bodies award work to this supplier.

Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i

What kinds of public bodies award work to this supplier.

Its award records by the authority’s published type, otherwise by its name. One framework can add many records.

  • NHS & health89%(24 awards)
    24 of 27 awards are NHS & health (89%).
  • Central government11%(3 awards)
    3 of 27 awards are Central government (11%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 141463.6%1710 Apr 2026
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 4418.2%67 Feb 2022
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency29.1%21 Jun 2026
Department of Health & Social Care29.1%223 Feb 2022

Share = of the 22 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

Contracts that finish in the next 18 months.

Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.

An end date does not confirm a new procurement.

17 of 27 awards carry an end date · not a retender forecast

ContractEndsPublished value
NHS National Framework for Transition products (Nilotinib and Ticagrelor)31 Jan 2027£22,097,000

Recent awards

Latest 27 of 27 award records naming this supplier

Award / procedureAuthorityAwardedPublished value
NHS National Branded Interim - 1 June 2026NHS England10 Apr 2026£529,090,780
framework ceiling · 1 of 51 appointed suppliers
NHS National Framework for Transition products (Nilotinib and Ticagrelor)NHS England12 Jun 2025£22,097,000
framework ceiling · 1 of 8 appointed suppliers
NHS National Framework for Transition products (Nilotinib and Ticagrelor)NHS England12 Jun 2025£22,097,000
framework ceiling · 1 of 8 appointed suppliers
Live Attenuated Influenza Vaccine 2026/2027Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencyNot published£225,408,000 †
from the contract notice
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NHS Framework for Branded Medicines - London & South of EnglandNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Lot 2 - CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual TrancheNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
About this data
  • Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions on this page are where the work is delivered, not the supplier’s registered address.
  • Contract end dates. Published on 17 of 27 awards, estimated from the published duration on 0 more (marked “estimated”); those feed “Contracts ending”.
  • Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.